Safety, Tolerability, and Pharmacokinetics of a Novel Mitochondrial Modulator, TRC150094, in Overweight and Obese Subjects: A Randomized Phase-I Clinical Trial.

Front Pharmacol · 2021 · PMC8485898 · PMID 34603045

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In a subset with TG > 1.64 mmol/L, serum TG and intrahepatic TG exhibited a decreasing trend, although this did not translate into improvement in insulin sensitivity.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.